{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:07:31Z","timestamp":1785942451451,"version":"3.56.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04487-z","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T08:13:38Z","timestamp":1755677618000},"page":"1639-1655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeting mitochondrial metabolism to overcome hormone resistance in breast cancer"],"prefix":"10.1007","volume":"399","author":[{"given":"Abbas S.","family":"Neamah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadhel M.","family":"Lafta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Hassan Soliman","family":"Wadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"11","key":"4487_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3390\/dj12110357","volume":"12","author":"MM Abbass","year":"2024","unstructured":"Abbass MM, Rady D, El Moshy S, Ahmed Radwan I, Wadan A, D\u00f6rfer CE, Fawzy KM (2024) The temporomandibular joint and the human body: a new perspective on cross talk. Dent J 12(11):357. https:\/\/doi.org\/10.3390\/dj12110357","journal-title":"Dent J"},{"key":"4487_CR2","doi-asserted-by":"publisher","first-page":"6369","DOI":"10.1007\/s00210-024-03764-7","volume":"398","author":"MS Abdelhamid","year":"2025","unstructured":"Abdelhamid MS, Wadan AHS, Saad HA et al (2025) Nanoparticle innovations in targeted cancer therapy: advancements in antibody\u2013drug conjugates. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 398:6369\u20136389. https:\/\/doi.org\/10.1007\/s00210-024-03764-7","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"issue":"11","key":"4487_CR3","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1080\/03007995.2024.2407963","volume":"40","author":"LS Ali","year":"2024","unstructured":"Ali LS, Attia YAM, Mourad S, Halawa EM, Abd Elghaffar NH, Shokry S, Elekhnawy E (2024) The missing link between cancer stem cells and immunotherapy. Curr Med Res Opin 40(11):1963\u20131984. https:\/\/doi.org\/10.1080\/03007995.2024.2407963","journal-title":"Curr Med Res Opin"},{"key":"4487_CR4","doi-asserted-by":"crossref","unstructured":"Allen C, Rajib KD, Luis DG, Maria EL, Yasemin C, Mickensone A, Marko M (2020) \"The Impact of CRISPR-Cas9 on age-related disorders: from pathology to therapy.\" Aging and disease 11(4):895.","DOI":"10.14336\/AD.2019.0927"},{"key":"4487_CR5","doi-asserted-by":"publisher","unstructured":"Allemailem KS, Almatroudi A, Alsahli MA, Aljaghwani A, M El-Kady A, Rahmani AH, Khan AA (2021) Novel Strategies for Disrupting Cancer-Cell Functions with Mitochondria-Targeted Antitumor Drug\u2013Loaded Nanoformulations. Int J Nanomedicine 16:3907\u20133936. https:\/\/doi.org\/10.2147\/IJN.S303832","DOI":"10.2147\/IJN.S303832"},{"issue":"11","key":"4487_CR6","first-page":"24","volume":"6","author":"D Amarasiri","year":"2024","unstructured":"Amarasiri D (2024) The current strategies and future prospects for addressing the PI3K\/AKT\/Mtor pathway in breast cancer. American Journal of Multidisciplinary Research & Development (AJMRD) 6(11):24\u201340","journal-title":"American Journal of Multidisciplinary Research & Development (AJMRD)"},{"key":"4487_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12282-017-0812-x","volume":"25","author":"K Araki","year":"2018","unstructured":"Araki K, Miyoshi Y (2018) Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K\/Akt\/mTOR in estrogen receptor-positive, HER2-negative breast cancer. Breast Cancer 25:392\u2013401","journal-title":"Breast Cancer"},{"key":"4487_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr3431","volume":"15","author":"MD Aupperlee","year":"2013","unstructured":"Aupperlee MD, Leipprandt JR, Bennett JM, Schwartz RC, Haslam SZ (2013) Amphiregulin mediates progesterone-induced mammary ductal development during puberty. Breast Cancer Res 15:1\u201315","journal-title":"Breast Cancer Res"},{"issue":"1","key":"4487_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biom10010135","volume":"10","author":"R Avolio","year":"2020","unstructured":"Avolio R, Matassa DS, Criscuolo D, Landriscina M, Esposito F (2020) Modulation of mitochondrial metabolic reprogramming and oxidative stress to overcome chemoresistance in cancer. Biomolecules 10(1):135","journal-title":"Biomolecules"},{"issue":"21","key":"4487_CR10","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.3390\/cancers14215472","volume":"14","author":"A Badie","year":"2022","unstructured":"Badie A, Gaiddon C, Mellitzer G (2022) Histone deacetylase functions in gastric cancer: a therapeutic target? Cancers 14(21):5472","journal-title":"Cancers"},{"key":"4487_CR11","doi-asserted-by":"publisher","unstructured":"Bottje WG (2021) Mitochondrial physiology. Sturkie's Avian Physiology (Seventh Edition) 65\u201381. https:\/\/doi.org\/10.1016\/B978-0-12-819770-7.00043-8","DOI":"10.1016\/B978-0-12-819770-7.00043-8"},{"key":"4487_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.849962","volume":"10","author":"DP Boulton","year":"2022","unstructured":"Boulton DP, Caino MC (2022) Mitochondrial fission and fusion in tumor progression to metastasis. Front Cell Dev Biol 10:849962","journal-title":"Front Cell Dev Biol"},{"issue":"39","key":"4487_CR13","doi-asserted-by":"publisher","first-page":"7475","DOI":"10.1021\/acs.jpcb.2c04156","volume":"126","author":"AW Burgess","year":"2022","unstructured":"Burgess AW (2022) Regulation of signaling from the epidermal growth factor family. J Phys Chem B 126(39):7475\u20137485","journal-title":"J Phys Chem B"},{"issue":"2","key":"4487_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bbcan.2011.05.003","volume":"1816","author":"B Busser","year":"2011","unstructured":"Busser B, Sancey L, Brambilla E, Coll J-L, Hurbin A (2011) The multiple roles of amphiregulin in human cancer. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1816(2):119\u2013131","journal-title":"Biochimica et Biophysica Acta (BBA)-Reviews on Cancer"},{"issue":"6","key":"4487_CR15","first-page":"905","volume":"56","author":"C Chu","year":"2024","unstructured":"Chu C, Ru H, Chen Y, Xu J, Wang C, Jin Y (2024) Gallic acid attenuates LPS-induced inflammation in Caco-2 cells by suppressing the activation of the NF-\u03baB\/MAPK signaling pathway: Gallic acid alleviates the inflammation in Caco-2 cells. Acta Biochim Biophys Sin 56(6):905","journal-title":"Acta Biochim Biophys Sin"},{"issue":"7","key":"4487_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076834","volume":"24","author":"L Clusan","year":"2023","unstructured":"Clusan L, Ferri\u00e8re F, Flouriot G, Pakdel F (2023) A basic review on estrogen receptor signaling pathways in breast cancer. Int J Mol Sci 24(7):6834","journal-title":"Int J Mol Sci"},{"issue":"15","key":"4487_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/nu16152417","volume":"16","author":"G Corsetti","year":"2024","unstructured":"Corsetti G, Pasini E, Scarabelli TM, Romano C, Singh A, Scarabelli CC, Dioguardi FS (2024) Importance of energy, dietary protein sources, and amino acid composition in the regulation of metabolism: an indissoluble dynamic combination for life. Nutrients 16(15):2417","journal-title":"Nutrients"},{"issue":"1","key":"4487_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s40360-025-00907-1","volume":"26","author":"\u015e Demirkesen","year":"2025","unstructured":"Demirkesen \u015e, \u0130ria\u011fa\u00e7 Y, \u015eeber ES, Aral C (2025) Melatonin enhances everolimus efficacy in breast cancer by suppressing mTOR pathway activation and promoting apoptosis and mitochondrial function. BMC Pharmacol Toxicol 26(1):100. https:\/\/doi.org\/10.1186\/s40360-025-00907-1","journal-title":"BMC Pharmacol Toxicol"},{"issue":"3","key":"4487_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2022.151225","volume":"101","author":"J Di Gregorio","year":"2022","unstructured":"Di Gregorio J, Petricca S, Iorio R, Toniato E, Flati V (2022) Mitochondrial and metabolic alterations in cancer cells. Eur J Cell Biol 101(3):151225","journal-title":"Eur J Cell Biol"},{"key":"4487_CR20","doi-asserted-by":"crossref","unstructured":"Dinh DT, Russell DL (2022) Nuclear receptors in ovarian function Nuclear Receptors in Human Health and Disease (pp 41\u201358): Springer","DOI":"10.1007\/978-3-031-11836-4_3"},{"issue":"2","key":"4487_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/biology12020218","volume":"12","author":"S Dutta","year":"2023","unstructured":"Dutta S, Ganguly A, Chatterjee K, Spada S, Mukherjee S (2023) Targets of immune escape mechanisms in cancer: basis for development and evolution of cancer immune checkpoint inhibitors. Biology 12(2):218","journal-title":"Biology"},{"issue":"1","key":"4487_CR22","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1038\/s41467-023-40022-5","volume":"14","author":"R El-Botty","year":"2023","unstructured":"El-Botty R, Morriset L, Montaudon E, Tariq Z, Schnitzler A, Bacci M, Dahmani A (2023) Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers. Nat Commun 14(1):4221","journal-title":"Nat Commun"},{"key":"4487_CR23","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1007\/s00210-024-03675-7","volume":"398","author":"DES Ellakwa","year":"2025","unstructured":"Ellakwa DES, Abdelmalek MA, Mostafa MM et al (2025) MircoRNAs predict and modulate responses to chemotherapy in leukemic patients. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 398:6221\u20136238. https:\/\/doi.org\/10.1007\/s00210-024-03675-7","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"4487_CR24","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1007\/s00210-024-03076-w","volume":"397","author":"DES Ellakwa","year":"2024","unstructured":"Ellakwa DES, Mushtaq N, Khan S et al (2024) Molecular functions of micrornas in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance. Naunyn-Schmiedebergs Arch Pharmacol 397:5617\u20135630. https:\/\/doi.org\/10.1007\/s00210-024-03076-w","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"4487_CR25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","volume":"8","author":"T Fan","year":"2023","unstructured":"Fan T, Zhang M, Yang J, Zhu Z, Cao W, Dong C (2023) Therapeutic cancer vaccines: advancements, challenges, and prospects. Signal Transduct Target Ther 8(1):450","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"4487_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/PPO.0000000000000607","volume":"28","author":"N Gautam","year":"2022","unstructured":"Gautam N, Elleson KM, Ramamoorthi G, Czerniecki BJ (2022) Current state of cell therapies for breast cancer. Cancer J 28(4):301\u2013309","journal-title":"Cancer J"},{"issue":"1","key":"4487_CR27","volume":"1878","author":"A Grinshpun","year":"2023","unstructured":"Grinshpun A, Chen V, Sandusky ZM, Fanning SW, Jeselsohn R (2023) ESR1 activating mutations: from structure to clinical application. Biochimica et Biophysica Acta (BBA) 1878(1):188830","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"4487_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122684","volume":"348","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Lin M, Zeng C, Zhang J (2024) NF-\u03baB signaling in therapy resistance of breast cancer: mechanisms, approaches, and challenges. Life Sci 348:122684","journal-title":"Life Sci"},{"key":"4487_CR29","doi-asserted-by":"publisher","unstructured":"Hsu CYi, Ahmed FM, Sandra P, Indira P, Mohammed AM, Mohamed J.S,\u00a0 Mohaned A (2024) \"Amphiregulin in infectious diseases: Role, mechanism, and potential therapeutic targets.\" Microb Pathog 186:106463.\u00a0https:\/\/doi.org\/10.1016\/j.micpath.2023.106463","DOI":"10.1016\/j.micpath.2023.106463"},{"key":"4487_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05047-4","volume":"22","author":"R Iorio","year":"2024","unstructured":"Iorio R, Petricca S, Mattei V, Delle Monache S (2024) Horizontal mitochondrial transfer as a novel bioenergetic tool for mesenchymal stromal\/stem cells: molecular mechanisms and therapeutic potential in a variety of diseases. J Transl Med 22:491. https:\/\/doi.org\/10.1186\/s12967-024-05047-4","journal-title":"J Transl Med"},{"issue":"10","key":"4487_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102402","volume":"14","author":"H Jafari","year":"2022","unstructured":"Jafari H, Hussain S, Campbell MJ (2022) Nuclear receptor coregulators in hormone-dependent cancers. Cancers 14(10):2402","journal-title":"Cancers"},{"key":"4487_CR32","doi-asserted-by":"publisher","unstructured":"Kakafika MG, Areti AL, George IG, Stefanos AT, Androulla NM, Ioannis SP, Ioannis SV, Lefkothea CP, Asterios ST (2024) \"Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K-562 and colorectal HCT-116 cancer cells.\" Int J Oncol 64(4):42. https:\/\/doi.org\/10.3892\/ijo.2024.5630","DOI":"10.3892\/ijo.2024.5630"},{"key":"4487_CR33","doi-asserted-by":"crossref","unstructured":"Kai C, Patrick E, Anusua S, Seulhee K, Yingnan Si, Tanvi V, Matthew DR, Xiaoguang\u00a0 Margaret L, Lufang Z (2024) \"mLumiOpto is a mitochondrial-targeted gene therapy for treating cancer.\" Cancer Research 84(23):4049\u20134065.","DOI":"10.1158\/0008-5472.CAN-24-0984"},{"issue":"13","key":"4487_CR34","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.2217\/fon-2020-0504","volume":"17","author":"C Kay","year":"2021","unstructured":"Kay C, Mart\u00ednez-P\u00e9rez C, Meehan J, Gray M, Webber V, Dixon JM, Turnbull AK (2021) Current trends in the treatment of HR+\/HER2+ breast cancer. Future Oncol 17(13):1665\u20131681","journal-title":"Future Oncol"},{"key":"4487_CR35","doi-asserted-by":"publisher","unstructured":"Krupnova AD, \u0426o\u043cap\u0442o\u0432a \u0414A, Chereshneva EV, Ivanova MY, Tsomartova ES, Lomanovskaya TA, Pavlova MS, Payushina OV (2024) Mitochondrial donation as a mechanism of participation by mesenchymal stromal cells in regenerative processes. Biologicheskie Membrany 41(4):297\u2013308. https:\/\/doi.org\/10.31857\/s0233475524040026","DOI":"10.31857\/s0233475524040026"},{"issue":"1","key":"4487_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12929-022-00859-2","volume":"29","author":"C-L Kuo","year":"2022","unstructured":"Kuo C-L, Ponneri Babuharisankar A, Lin Y-C, Lien H-W, Lo YK, Chou H-Y, Lee AY-L (2022) Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend? J Biomed Sci 29(1):74","journal-title":"J Biomed Sci"},{"key":"4487_CR37","doi-asserted-by":"publisher","unstructured":"Lei JT, Gou X, Seker S, Ellis MJ (2019) ESR1 alterations and metastasis in estrogen receptor positive breast cancer. J Cancer Metastasis Treat 5:38. https:\/\/doi.org\/10.20517\/2394-4722.2019.12","DOI":"10.20517\/2394-4722.2019.12"},{"issue":"14","key":"4487_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143517","volume":"13","author":"H Li","year":"2021","unstructured":"Li H, Prever L, Hirsch E, Gulluni F (2021) Targeting PI3K\/AKT\/mTOR signaling pathway in breast cancer. Cancers 13(14):3517","journal-title":"Cancers"},{"issue":"1","key":"4487_CR39","doi-asserted-by":"publisher","first-page":"9919868","DOI":"10.1155\/2024\/9919868","volume":"2024","author":"MA Madkour","year":"2023","unstructured":"Madkour MA, Altaf RA, Sayed ZS, Yasen NS, Elbary HA, Elsayed RA, Mohamed EN, Toema M, Wadan HS, Nafady MH, El-Benhawy SA (2023) The role of gut microbiota in modulating cancer therapy efficacy. Adv Gut Microbiome Res 2024(1):9919868. https:\/\/doi.org\/10.1155\/2024\/9919868","journal-title":"Adv Gut Microbiome Res"},{"issue":"4","key":"4487_CR40","first-page":"217","volume":"11","author":"I Mayer","year":"2013","unstructured":"Mayer I (2013) Role of mTOR inhibition in preventing resistance and restoring sensitivity to hormone-targeted and HER2-targeted therapies in breast cancer. Clin Adv Hematol Oncol: H&O 11(4):217","journal-title":"Clin Adv Hematol Oncol: H&O"},{"key":"4487_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jconrel.2023.09.023","volume":"363","author":"LS Milane","year":"2023","unstructured":"Milane LS, Dolare S, Ren G, Amiji M (2023) Combination organelle mitochondrial endoplasmic reticulum therapy (COMET) for multidrug resistant breast cancer. J Control Release 363:435\u2013451. https:\/\/doi.org\/10.1016\/j.jconrel.2023.09.023","journal-title":"J Control Release"},{"key":"4487_CR42","doi-asserted-by":"publisher","DOI":"10.3791\/55245","volume":"120","author":"BN Mombo","year":"2017","unstructured":"Mombo BN, Gerbal-Chaloin S, Bokus A, Daujat-Chavanieu M, Jorgensen C, Hugnot J-P, Vignais M-L (2017) Mitoception: transferring isolated human MSC mitochondria to glioblastoma stem cells. J Vis Exp 120:55245. https:\/\/doi.org\/10.3791\/55245","journal-title":"J Vis Exp"},{"key":"4487_CR43","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s001220050456","volume":"94","author":"T Nagaoka","year":"1997","unstructured":"Nagaoka T, Ogihara Y (1997) Applicability of inter-simple sequence repeat polymorphisms in wheat for use as DNA markers in comparison to RFLP and RAPD markers. Theor Appl Genet 94:597\u2013602","journal-title":"Theor Appl Genet"},{"key":"4487_CR44","doi-asserted-by":"publisher","unstructured":"Neamah AS, Lafta FM (2024) Diagnostic potential role of CXCL3 and leptin levels in breast cancer. (2024). Iraqi J Sci 65(4):1929\u20131939. https:\/\/doi.org\/10.24996\/ijs.2024.65.4.13","DOI":"10.24996\/ijs.2024.65.4.13"},{"key":"4487_CR45","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1007\/s00210-024-03592-9","volume":"398","author":"AS Neamah","year":"2025","unstructured":"Neamah AS, Wadan AHS, Lafta FM et al (2025) The potential role of targeting the leptin receptor as a treatment for breast cancer in the context of hyperleptinemia: a literature review. Naunyn-Schmiedebergs Arch Pharmacol 398:3451\u20133466. https:\/\/doi.org\/10.1007\/s00210-024-03592-9","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"4487_CR46","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.semcancer.2020.07.015","volume":"83","author":"ME Neganova","year":"2022","unstructured":"Neganova ME, Klochkov SG, Aleksandrova YR, Aliev G (2022) Histone modifications in epigenetic regulation of cancer: perspectives and achieved progress. Semin Cancer Biol 83:452\u2013471. https:\/\/doi.org\/10.1016\/j.semcancer.2020.07.015","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"4487_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030574","volume":"12","author":"NYL Ngoi","year":"2020","unstructured":"Ngoi NYL, Choong C, Lee J, Bellot G, Wong AL, Goh BC, Pervaiz S (2020) Targeting mitochondrial apoptosis to overcome treatment resistance in cancer. Cancers (Basel) 12(3):574","journal-title":"Cancers (Basel)"},{"issue":"8","key":"4487_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087076","volume":"24","author":"N Niu","year":"2023","unstructured":"Niu N, Ye J, Hu Z, Zhang J, Wang Y (2023) Regulative roles of metabolic plasticity caused by mitochondrial oxidative phosphorylation and glycolysis on the initiation and progression of tumorigenesis. Int J Mol Sci 24(8):7076","journal-title":"Int J Mol Sci"},{"key":"4487_CR49","doi-asserted-by":"publisher","unstructured":"Outschoorn M, Ubaldo E, Allison FG, Zhao L, Ying-Hui K, Neal F, Chenguang W, Stephanos P et al (2011) \"Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells.\" Cancer bio ther 12(10 ):924\u2013938.\u00a0https:\/\/doi.org\/10.4161\/cbt.12.10.17780","DOI":"10.4161\/cbt.12.10.17780"},{"issue":"21","key":"4487_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215206","volume":"14","author":"R Ozyurt","year":"2022","unstructured":"Ozyurt R, Ozpolat B (2022) Molecular mechanisms of anti-estrogen therapy resistance and novel targeted therapies. Cancers (Basel) 14(21):5206","journal-title":"Cancers (Basel)"},{"key":"4487_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2023.101149","volume":"6","author":"C Pal","year":"2023","unstructured":"Pal C (2023) Mitochondria-targeted metallo-drugs against cancer: a current mechanistic perspective. Results Chem 6:101149. https:\/\/doi.org\/10.1016\/j.rechem.2023.101149","journal-title":"Results Chem"},{"issue":"5","key":"4487_CR52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41388-023-02907-z","volume":"43","author":"FR Palma","year":"2024","unstructured":"Palma FR, Gantner BN, Sakiyama MJ, Kayzuka C, Shukla S, Lacchini R, Bonini MG (2024) ROS production by mitochondria: function or dysfunction? Oncogene 43(5):295\u2013303","journal-title":"Oncogene"},{"issue":"12","key":"4487_CR53","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2912402","volume":"29","author":"C Papaneophytou","year":"2024","unstructured":"Papaneophytou C (2024) The Warburg effect: is it always an enemy? Front Biosci-Landmark 29(12):402","journal-title":"Front Biosci-Landmark"},{"key":"4487_CR54","doi-asserted-by":"crossref","unstructured":"Pandya SR, Harjeet S, Martin FD, Jagpreet S, Noble G, Srushti J (2024) \"Circumventing challenges in mitochondrial targeting for cancer treatment: leveraging nanoplatforms for effective solutions.\" Materials Advances 5(2):409\u2013431","DOI":"10.1039\/D3MA00629H"},{"key":"4487_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.985363","volume":"12","author":"S Qian","year":"2022","unstructured":"Qian S, Wei Z, Yang W, Huang J, Yang Y, Wang J (2022) The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front Oncol 12:985363","journal-title":"Front Oncol"},{"key":"4487_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.628359","volume":"11","author":"J Qiu","year":"2021","unstructured":"Qiu J, Zheng Q, Meng X (2021) Hyperglycemia and chemoresistance in breast cancer: from cellular mechanisms to treatment response. Front Oncol 11:628359","journal-title":"Front Oncol"},{"issue":"3","key":"4487_CR57","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2478\/enr-2022-0025","volume":"56","author":"V Rambani","year":"2022","unstructured":"Rambani V, Hromnikova D, Gasperikova D, Skopkova M (2022) Mitochondria and mitochondrial disorders: an overview update. Endocr Regul 56(3):232\u2013248","journal-title":"Endocr Regul"},{"key":"4487_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2021.111322","volume":"532","author":"F Rasha","year":"2021","unstructured":"Rasha F, Sharma M, Pruitt K (2021) Mechanisms of endocrine therapy resistance in breast cancer. Mol Cell Endocrinol 532:111322","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"4487_CR59","doi-asserted-by":"publisher","first-page":"18653","DOI":"10.1038\/s41598-023-45738-4","volume":"13","author":"A Raugh","year":"2023","unstructured":"Raugh A, Jing Y, Bettini ML, Bettini M (2023) The amphiregulin\/EGFR axis has limited contribution in controlling autoimmune diabetes. Sci Rep 13(1):18653","journal-title":"Sci Rep"},{"issue":"1","key":"4487_CR60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.14218\/OnA.2025.00001","volume":"3","author":"B Ruidas","year":"2025","unstructured":"Ruidas B (2025) Mitochondrial dynamics in breast cancer metastasis: from metabolic drivers to therapeutic targets. Oncol Adv 3(1):39\u201349. https:\/\/doi.org\/10.14218\/OnA.2025.00001","journal-title":"Oncol Adv"},{"issue":"12","key":"4487_CR61","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s00109-021-02136-5","volume":"99","author":"O Saatci","year":"2021","unstructured":"Saatci O, Huynh-Dam K-T, Sahin O (2021) Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies. J Mol Med 99(12):1691\u20131710","journal-title":"J Mol Med"},{"issue":"4","key":"4487_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13040990","volume":"13","author":"H Sabit","year":"2025","unstructured":"Sabit H, Abouelnour S, Hassen BM, Magdy S, Yasser A, Wadan A, Radwan F, Alqosaibi AI, Hafiz H, Awlya OF, Arneth B (2025a) Anticancer potential of prebiotics: targeting estrogen receptors and PI3K\/AKT\/mTOR in breast cancer. Biomedicines 13(4):990. https:\/\/doi.org\/10.3390\/biomedicines13040990","journal-title":"Biomedicines"},{"key":"4487_CR63","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-025-02357-z","volume":"24","author":"H Sabit","year":"2025","unstructured":"Sabit H, Pawlik TM, Radwan F et al (2025b) Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery. Mol Cancer 24:160. https:\/\/doi.org\/10.1186\/s12943-025-02357-z","journal-title":"Mol Cancer"},{"key":"4487_CR64","doi-asserted-by":"publisher","unstructured":"Santacana Font\u00a0G (2023) Molecular dynamics of breast cancer response to aromatase inhibitors treatment. Annals of the University of Salamanca. https:\/\/doi.org\/10.14201\/gredos.158285","DOI":"10.14201\/gredos.158285"},{"key":"4487_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119942","volume":"284","author":"FL Sarmiento-Salinas","year":"2021","unstructured":"Sarmiento-Salinas FL, Perez-Gonzalez A, Acosta-Casique A, Ix-Ballote A, Diaz A, Trevi\u00f1o S, Maycotte P (2021) Reactive oxygen species: role in carcinogenesis, cancer cell signaling and tumor progression. Life Sci 284:119942","journal-title":"Life Sci"},{"issue":"8","key":"4487_CR66","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/emmm.201101131","volume":"4","author":"NA Saunders","year":"2012","unstructured":"Saunders NA, Simpson F, Thompson EW, Hill MM, Endo-Munoz L, Leggatt G, Guminski A (2012) Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives. EMBO Mol Med 4(8):675\u2013684","journal-title":"EMBO Mol Med"},{"issue":"1","key":"4487_CR67","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12672-024-00949-7","volume":"15","author":"ZS Sayed","year":"2024","unstructured":"Sayed ZS, Khattap MG, Madkour MA, Yasen NS, Elbary HA, Elsayed RA, Nafady MH (2024a) Circulating tumor cells clusters and their role in breast cancer metastasis; a review of literature. Discover Oncol 15(1):94","journal-title":"Discover Oncol"},{"key":"4487_CR68","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12672-024-00949-7","volume":"15","author":"ZS Sayed","year":"2024","unstructured":"Sayed ZS, Khattap MG, Madkour MA et al (2024b) Circulating tumor cells clusters and their role in breast cancer metastasis; a review of literature. Discov Oncol 15:94. https:\/\/doi.org\/10.1007\/s12672-024-00949-7","journal-title":"Discov Oncol"},{"issue":"5","key":"4487_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051056","volume":"10","author":"C Schiliro","year":"2021","unstructured":"Schiliro C, Firestein BL (2021) Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Cells 10(5):1056","journal-title":"Cells"},{"key":"4487_CR70","doi-asserted-by":"publisher","unstructured":"Sibio MTD, Moretto FCF, Olimpio RMC, Oliveira Md, Mathias LS, Peghinelli VV, ... Aqua LSD (2024) Triiodothyronine (T3) increases the expression of the amphiregulin (AREG) oncogene by activating extranuclear pathways in MCF-7 breast cancer cells. Arch Endocrinol Metab 68(special issue):e240094. https:\/\/doi.org\/10.20945\/2359-4292-2023-0094","DOI":"10.20945\/2359-4292-2023-0094"},{"key":"4487_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/JCP.30615","author":"SS Singh","year":"2021","unstructured":"Singh SS, Chauhan SB, Kumar A, Kumar S, Engwerda CR, Sundar S, Kumar R (2021) Amphiregulin in cellular physiology, health, and disease: potential use as a biomarker and therapeutic target. J Cell Physiol. https:\/\/doi.org\/10.1002\/JCP.30615","journal-title":"J Cell Physiol"},{"issue":"2","key":"4487_CR72","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/jcp.30615","volume":"237","author":"SS Singh","year":"2022","unstructured":"Singh SS, Chauhan SB, Kumar A, Kumar S, Engwerda CR, Sundar S, Kumar R (2022) Amphiregulin in cellular physiology, health, and disease: potential use as a biomarker and therapeutic target. J Cell Physiol 237(2):1143\u20131156","journal-title":"J Cell Physiol"},{"issue":"8","key":"4487_CR73","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2217\/epi-2023-0142","volume":"15","author":"D Singh","year":"2023","unstructured":"Singh D, Khan MA, Siddique HR (2023) Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements. Epigenomics 15(8):517\u2013537","journal-title":"Epigenomics"},{"key":"4487_CR74","doi-asserted-by":"publisher","unstructured":"S\u00f6zen S, Emir S (eds) (2023) Breast Cancer Updates. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.104150","DOI":"10.5772\/intechopen.104150"},{"key":"4487_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109735","volume":"351","author":"V Subramaniyan","year":"2022","unstructured":"Subramaniyan V, Fuloria S, Gupta G, Kumar DH, Sekar M, Sathasivam KV, Afzal O (2022) A review on epidermal growth factor receptor\u2019s role in breast and non-small cell lung cancer. Chem-Biol Interact 351:109735","journal-title":"Chem-Biol Interact"},{"key":"4487_CR76","doi-asserted-by":"publisher","unstructured":"Sukocheva OA, Lukina E, Friedemann M, Menschikowski M, Hagelgans A, Aliev G (2022) The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: current findings and future perspectives.\u00a0Semin Cancer Biol 82:35\u201359. https:\/\/doi.org\/10.1016\/j.semcancer.2020.12.004","DOI":"10.1016\/j.semcancer.2020.12.004"},{"key":"4487_CR77","doi-asserted-by":"crossref","unstructured":"Tai Y-H, Engels D, Locatelli G, Emmanouilidis I, Fecher C, Theodorou D, ..., Wagner I (2023) Targeting the TCA cycle can ameliorate widespread axonal energy deficiency in neuroinflammatory lesions. Nat Metab 5(8):1364\u20131381","DOI":"10.1038\/s42255-023-00838-3"},{"issue":"8","key":"4487_CR78","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/stcltm\/szac044","volume":"11","author":"Y-L Tan","year":"2022","unstructured":"Tan Y-L, Eng SP, Hafez P, Karim NA, Law JX, Ng MH (2022) Mesenchymal stromal cell mitochondrial transfer as a cell rescue strategy in regenerative medicine: a review of evidence in preclinical models. Stem Cells Transl Med 11(8):814\u2013827. https:\/\/doi.org\/10.1093\/stcltm\/szac044","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"4487_CR79","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1158\/0008-5472.CAN-24-1204","volume":"85","author":"S Tau","year":"2025","unstructured":"Tau S, Chamberlin MD, Yang H, Marotti JD, Muskus PC, Roberts AM, Carmichael MM, Cressey L, Dragnev CPC, Demidenko E, Hampsch RA, Soucy SM, Kolling FW, Samkoe KS, Alvarez JV, Kettenbach AN, Miller TW (2025) Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy-tolerant persister cells in ER+ breast cancer. Can Res 85(6):1145\u20131161. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-1204","journal-title":"Can Res"},{"issue":"8","key":"4487_CR80","doi-asserted-by":"publisher","first-page":"FSO883","DOI":"10.2144\/fsoa-2023-0067","volume":"9","author":"MM Tolba","year":"2023","unstructured":"Tolba MM, Jabbar A, Afzal S, Mahmoud M, Zulfiqar F, El-Soudany I, Ellakwa DES (2023) A promising RNA nanotechnology in clinical therapeutics: a future perspective narrative review. Future Sci OA 9(8):FSO883. https:\/\/doi.org\/10.2144\/fsoa-2023-0067","journal-title":"Future Sci OA"},{"key":"4487_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111055","volume":"396","author":"M Tufail","year":"2024","unstructured":"Tufail M, Wan W-D, Jiang C, Li N (2024) Targeting PI3K\/AKT\/mTOR signaling to overcome drug resistance in cancer. Chem Biol Interact 396:111055","journal-title":"Chem Biol Interact"},{"issue":"1","key":"4487_CR82","first-page":"35","volume":"6","author":"S Tutuncu","year":"2023","unstructured":"Tutuncu S, Ozdemir B (2023) Fundamental molecules in the pathways and regulation of apoptosis. Int J Vet Anim Res (IJVAR) 6(1):35\u201338","journal-title":"Int J Vet Anim Res (IJVAR)"},{"issue":"21","key":"4487_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15215242","volume":"15","author":"L Varisli","year":"2023","unstructured":"Varisli L, Dancik GM, Tolan V, Vlahopoulos S (2023) Critical roles of SRC-3 in the development and progression of breast cancer, rendering it a prospective clinical target. Cancers (Basel) 15(21):5242","journal-title":"Cancers (Basel)"},{"key":"4487_CR84","doi-asserted-by":"publisher","unstructured":"Velarde F, Sarah E, Xavier D, Andres C, Yessia H, Maroun K (2022) \"Mesenchymal stem cell-mediated transfer of mitochondria: mechanisms and functional impact.\" Cell Mol Life Sci 79(3):177. https:\/\/doi.org\/10.1007\/s00018-022-04207-3","DOI":"10.1007\/s00018-022-04207-3"},{"issue":"2","key":"4487_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2021.100504","volume":"21","author":"J Wang","year":"2021","unstructured":"Wang J, Wu J, Zhang Y, Zhang J, Xu W, Wu C, Zhou P (2021a) Growth hormone protects against ovarian granulosa cell apoptosis: alleviation oxidative stress and enhancement mitochondrial function. Reprod Biol 21(2):100504","journal-title":"Reprod Biol"},{"key":"4487_CR86","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canlet.2021.09.043","volume":"523","author":"S-F Wang","year":"2021","unstructured":"Wang S-F, Chang Y-L, Tzeng Y-D, Wu C-L, Wang Y-Z, Tseng L-M, Lee H-C (2021b) Mitochondrial stress adaptation promotes resistance to aromatase inhibitor in human breast cancer cells via ROS\/calcium up-regulated amphiregulin\u2013estrogen receptor loop signaling. Cancer Lett 523:82\u201399","journal-title":"Cancer Lett"},{"issue":"1","key":"4487_CR87","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","volume":"8","author":"N Wang","year":"2023","unstructured":"Wang N, Ma T, Yu B (2023a) Targeting epigenetic regulators to overcome drug resistance in cancers. Signal Transduct Target Ther 8(1):69","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4487_CR88","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12929-023-00956-w","volume":"30","author":"S-F Wang","year":"2023","unstructured":"Wang S-F, Tseng L-M, Lee H-C (2023b) Role of mitochondrial alterations in human cancer progression and cancer immunity. J Biomed Sci 30(1):61","journal-title":"J Biomed Sci"},{"issue":"2","key":"4487_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6987","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, Harada-Shoji N, Kitamura N, Yamazaki Y, Ebata A, Amari M, Watanabe M, Miyashita M, Tada H, Abe T, Suzuki T, Gonda K, Ishida T (2023c) Mitochondrial dynamics as a novel treatment strategy for triple-negative breast cancer. Cancer Med 13(2):e6987. https:\/\/doi.org\/10.1002\/cam4.6987","journal-title":"Cancer Med"},{"issue":"5","key":"4487_CR90","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.7150\/ijbs.92125","volume":"20","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang W, Liu C, Wang L, Wu J, Sun C, Wu Q (2024) Reprogramming of lipid metabolism mediates crosstalk, remodeling, and intervention of microenvironment components in breast cancer. Int J Biol Sci 20(5):1884","journal-title":"Int J Biol Sci"},{"key":"4487_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115676","volume":"168","author":"M Wyla\u017a","year":"2023","unstructured":"Wyla\u017a M, Kaczmarska A, Pajor D, Hryniewicki M, Gil D, Duli\u0144ska-Litewka J (2023) Exploring the role of PI3K\/AKT\/mTOR inhibitors in hormone-related cancers: a focus on breast and prostate cancer. Biomed Pharmacother 168:115676","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"4487_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18083874","volume":"18","author":"S-S Zhang","year":"2021","unstructured":"Zhang S-S, Zhou S, Crowley-McHattan ZJ, Wang R-Y, Li J-P (2021a) A review of the role of endo\/sarcoplasmic reticulum-mitochondria Ca2+ transport in diseases and skeletal muscle function. Int J Environ Res Public Health 18(8):3874","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"4487_CR93","doi-asserted-by":"publisher","first-page":"20210115","DOI":"10.1002\/EXP.20210115","volume":"1","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Yang H, Wei D, Zhang X, Wang J, Wu X, Chang J (2021b) Mitochondria\u2010targeted nanoparticles in treatment of neurodegenerative diseases. Exploration 1(3):20210115. https:\/\/doi.org\/10.1002\/EXP.20210115","journal-title":"Exploration"},{"key":"4487_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1072651","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Wang G, Li Y, Lei D, Xiang J, Ouyang L, Yang J (2022) Recent progress in DNA methyltransferase inhibitors as anticancer agents. Front Pharmacol 13:1072651","journal-title":"Front Pharmacol"},{"key":"4487_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113825","volume":"226","author":"M Zhou","year":"2021","unstructured":"Zhou M, Yuan M, Zhang M, Lei C, Aras O, Zhang X, An F (2021) Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy. Eur J Med Chem 226:113825","journal-title":"Eur J Med Chem"},{"issue":"4","key":"4487_CR96","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41418-024-01284-8","volume":"31","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Arroum T, Luo X, Kang R, Lee YJ, Tang D, Song X (2024) Diverse functions of cytochrome c in cell death and disease. Cell Death Differ 31(4):387\u2013404","journal-title":"Cell Death Differ"},{"key":"4487_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00950","volume":"10","author":"D Zilenaite","year":"2020","unstructured":"Zilenaite D, Rasmusson A, Augulis R, Besusparis J, Laurinaviciene A, Plancoulaine B, Laurinavicius A (2020) Independent prognostic value of intratumoral heterogeneity and immune response features by automated digital immunohistochemistry analysis in early hormone receptor-positive breast carcinoma. Front Oncol 10:950","journal-title":"Front Oncol"},{"issue":"22","key":"4487_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214152","volume":"23","author":"ERM Zunica","year":"2022","unstructured":"Zunica ERM, Axelrod CL, Kirwan JP (2022) Phytochemical targeting of mitochondria for breast cancer chemoprevention, therapy, and sensitization. Int J Mol Sci 23(22):14152. https:\/\/doi.org\/10.3390\/ijms232214152","journal-title":"Int J Mol Sci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04487-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04487-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04487-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T02:02:55Z","timestamp":1771552975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04487-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4487"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04487-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This information has not been previously presented in any form. The authors confirm that no paper mill and no artificial intelligence were used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}